Siponimod versus placebo in secondary progressive multiple s…
Siponimod versus placebo in secondary progressive multiple sclerosis %25252528EXPAND%25252529%2525253A a double-blind%2525252C randomized%2525252C phase 3 study
Article, Chapter
Full text availability for this item
Journal:
Lancet, TheOpens in new Window
Collection:
Elsevier ScienceDirect Journals
Coverage:
- 1823-10-05~present
Collection:
Business Source Complete
Coverage:
- 1991-01-05~2006-12-24